Key result
Orally administered reviparin sodium produced a dose-dependent reduction in thrombosis incidence and was recovered from endothelium and plasma in a rat model.
Why the study?
Does orally administered reviparin sodium reduce thrombosis incidence in a rat model?
Does orally administered reviparin sodium reduce thrombosis incidence in a rat model?
Orally administered reviparin sodium is absorbed and demonstrates dose-dependent antithrombotic activity in a rat model.
Answers are grounded in this paper and cite their sources.
Does not support clinical use; leaves open translation of oral heparin antithrombotic activity to humans.
Previous studies in rats show that unfractionated heparin and the low molecular weight heparin logiparin have a dose-dependent antithrombotic effect and are found in endothelium and plasma when administered orally. Objectives of the present study were to determine if similar evidence of absorption could be observed with oral reviparin sodium. Thrombosis incidence was determined 4 h after application of 10% formalin in methanol to the exposed jugular vein. A dose-dependent antithrombotic effect was observed when 0.01 to 7.5 mg/kg (20 rats/group) was administered by stomach tube immediately following thrombus initiation. Thrombotic incidence was also significantly reduced when 0.025 mg/kg was given 4 and 2 h prior to, immediately after, and 2 and 3 h following thrombus initiation. Reviparin was recovered from endothelium and plasma in trace amounts at all doses. At 0.025 mg/kg, peak aortic endothelial reviparin concentrations were found at 1 and 2 h and peak plasma anti-Xa activity was detected at 2 h. Trace amounts of plasma TFPI were found only at 8 h after administration. Dose-dependent antithrombotic activity and recovery from endothelium and plasma support the hypothesis that orally administered reviparin sodium is absorbed.
No takes yet. Share an insight, caveat, or question.
A 2001 study studied Thrombosis. Oral reviparin sodium was evaluated on Thrombosis incidence. Orally administered reviparin sodium produced a dose-dependent reduction in thrombosis incidence and was recovered from endothelium and plasma in a rat model.
Synapse has enriched 10 related papers. Consider them for comparative context: